# TAK-438 Bismuth Drug Interaction Study

> **NCT02892409** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 30 (actual)

## Conditions studied

- Helicobacter Pylori

## Interventions

- **DRUG:** Clarithromycin
- **DRUG:** Amoxicillin
- **DRUG:** Tripotassium bismuth dicitrate
- **DRUG:** Lansoprazole
- **DRUG:** TAK-438

## Key facts

- **NCT ID:** NCT02892409
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-05
- **Primary completion:** 2017-04-17
- **Final completion:** 2017-05-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02892409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02892409, "TAK-438 Bismuth Drug Interaction Study". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02892409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*